In a research update to clients Wednesday, Tucci maintained his “Speculative Buy” rating, but lowered his one-year price target on Nubeva from $1.50 to $1.20, implying a return of 243 per cent at the time of publication.
The analyst explained his reasoning.
“We are bullish on the company’s pivot to focus on Prisms ahead of StratusEdge,” Tucci said. “We believe that this will lead to incremental longer term shareholder gains. However, we have tempered our near term momentum expectations as we wait for the prisms to gain customer trials and more importantly commercial adoption. In the context of a TSXV that declined 35% for 2018 and with an applicable ~20% discount rate within DCF valuations, we are reducing our PT by 20% to C$1.20 reflecting timing considerations and looking for visibility on a ramp in commercial revenues.”
Tucci thinks Nubeva will post Adjusted EBITDA of negative $1.4-million (all figures USD) on revenue of $2.4-million in fiscal 2019. He expects those numbers will improve to EBITDA of negative $200,000 on a topline of $1.9-million the following year.
Paradigm Capital analyst Daniel Rosenberg reiterated a “Buy” rating and C$1.50 target price on Sabio Holdings (Sabio Holdings Stock Quote,… [Read More]
National Bank Financial Capital Markets analyst Gabriel Dechaine cut his target for EQB (EQB Stock Quote, Chart, News, Analysts, Financials… [Read More]
Roth Capital Markets analyst Scott Searle maintained a “Buy” rating and $8.00 target for Lantronix (Lantronix Stock Quote, Chart, News,… [Read More]
Beacon Securities analyst Gabriel Leung maintained a “Buy” rating and C$2.25 target price for Avante (Avante Stock Quote, Chart, News,… [Read More]
Roth Capital Markets analyst Darren Aftahi raised his 12-month price target for Hut 8 (Hut 8 Stock Quote, Chart, News,… [Read More]
RBC Capital Markets says artificial intelligence is reshaping Canada’s technology sector, with adoption accelerating across industries and positioning the country… [Read More]